NEOS S&P 500 High Income ETF vs 22nd Century Group Inc — how do they compare? NEOS S&P 500 High Income ETF trades at $54.06 (market cap $12.50B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: NEOS S&P 500 High Income ETF is far larger — about 20107.1× 22nd Century Group Inc's market cap, and NEOS S&P 500 High Income ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NEOS S&P 500 High Income ETF for 58 Days and 22nd Century Group Inc for 32 Days on average.
| SPYI | XXII | |
|---|---|---|
Market Cap | $12.50B | $621.67K |
Volume | 3,058,962 | 45,625 |
Sector | Income / Options Overlay | Consumer Staples |
52-Week High | $54.42 | $483.00 |
52-Week Low | $47.98 | $0.80 |
Typical Hold Time | 58 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
SPYI trades at $54.09 with a slight 0.15% daily gain, showing modest upward momentum amid bullish technical signals. The ETF maintains a strong income focus with recent monthly dividends around $0.53-0.54, though key valuation metrics remain unavailable. Technical analysis indicates bullish moving averages but neutral oscillators, with RSI-6 suggesting potential overbought conditions at 72.22.
SPYI offers high-income generation through covered call strategies but faces principal erosion risks as highlighted in recent analysis. The ETF's 12% yield attracts retirement investors, though coverage warns of potential capital depletion with systematic withdrawals. Market sentiment remains mixed between income appeal and long-term growth concerns.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →